Fortimicin C and process for production thereof

- Abbott Laboratories

A new antibiotic, Fortimicin C, is produced by fermentation of a microorganism belonging to the genus Micromonospora. The antibiotic is accumulated in the culture medium and is isolated therefrom.

Skip to:  ·  Claims  ·  References Cited  · Patent History  ·  Patent History

Claims

1. Fortimicin C, a composition of matter having an antibacterial activity, having the following structural formula: ##STR3##

2. A pharmaceutically acceptable acid addition salt of the composition of matter of claim 1, said acid addition salt being selected from the group consisting of the hydrochloride, hydrobromide, hydroiodide, sulfate, sulfamate, phosphate, maleate, acetate, citrate, oxalate, succinate, benzoate, tartrate, fumarate, malate, mandelate and ascorbate.

Referenced Cited
U.S. Patent Documents
3931400 January 6, 1976 Nara et al.
3976768 August 24, 1976 Nara et al.
Patent History
Patent number: 4097428
Type: Grant
Filed: May 26, 1977
Date of Patent: Jun 27, 1978
Assignee: Abbott Laboratories (North Chicago, IL)
Inventors: Takashi Nara (Tokyo), Ryo Okachi (Machida), Mitsuyoshi Yamamoto (Machida), Yasuki Mori (Kawasaki), Moriyuki Sato (Machida), Masahiro Sugimoto (Shizuoka), Yoshiaki Shimizu (Shizuoka)
Primary Examiner: Nicky Chan
Law Firm: Fitzpatrick, Cella, Harper & Scinto
Application Number: 5/800,925
Classifications
Current U.S. Class: 260/3459R
International Classification: C07D30922;